Literature DB >> 26041846

Proteotranscriptomic Profiling of 231-BR Breast Cancer Cells: Identification of Potential Biomarkers and Therapeutic Targets for Brain Metastasis.

Matthew D Dun1, Robert J Chalkley2, Sam Faulkner1, Sheridan Keene1, Kelly A Avery-Kiejda1, Rodney J Scott1, Lasse G Falkenby3, Murray J Cairns1, Martin R Larsen3, Ralph A Bradshaw2, Hubert Hondermarck4.   

Abstract

Brain metastases are a devastating consequence of cancer and currently there are no specific biomarkers or therapeutic targets for risk prediction, diagnosis, and treatment. Here the proteome of the brain metastatic breast cancer cell line 231-BR has been compared with that of the parental cell line MDA-MB-231, which is also metastatic but has no organ selectivity. Using SILAC and nanoLC-MS/MS, 1957 proteins were identified in reciprocal labeling experiments and 1584 were quantified in the two cell lines. A total of 152 proteins were confidently determined to be up- or down-regulated by more than twofold in 231-BR. Of note, 112/152 proteins were decreased as compared with only 40/152 that were increased, suggesting that down-regulation of specific proteins is an important part of the mechanism underlying the ability of breast cancer cells to metastasize to the brain. When matched against transcriptomic data, 43% of individual protein changes were associated with corresponding changes in mRNA, indicating that the transcript level is a limited predictor of protein level. In addition, differential miRNA analyses showed that most miRNA changes in 231-BR were up- (36/45) as compared with down-regulations (9/45). Pathway analysis revealed that proteome changes were mostly related to cell signaling and cell cycle, metabolism and extracellular matrix remodeling. The major protein changes in 231-BR were confirmed by parallel reaction monitoring mass spectrometry and consisted in increases (by more than fivefold) in the matrix metalloproteinase-1, ephrin-B1, stomatin, myc target-1, and decreases (by more than 10-fold) in transglutaminase-2, the S100 calcium-binding protein A4, and l-plastin. The clinicopathological significance of these major proteomic changes to predict the occurrence of brain metastases, and their potential value as therapeutic targets, warrants further investigation.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26041846      PMCID: PMC4563718          DOI: 10.1074/mcp.M114.046110

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  77 in total

1.  Epidemiology of brain metastases.

Authors:  Lakshmi Nayak; Eudocia Quant Lee; Patrick Y Wen
Journal:  Curr Oncol Rep       Date:  2012-02       Impact factor: 5.075

Review 2.  S100A4 and metastasis: a small actor playing many roles.

Authors:  Kjetil Boye; Gunhild M Maelandsmo
Journal:  Am J Pathol       Date:  2009-12-17       Impact factor: 4.307

Review 3.  The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis.

Authors:  Takeshi Imamura; Atsuhiko Hikita; Yasumichi Inoue
Journal:  Breast Cancer       Date:  2011-12-03       Impact factor: 4.239

4.  Targeting transmembrane TNF-α suppresses breast cancer growth.

Authors:  Mingxia Yu; Xiaoxi Zhou; Lin Niu; Guohong Lin; Jin Huang; Wenjing Zhou; Hui Gan; Jing Wang; Xiaodan Jiang; Bingjiao Yin; Zhuoya Li
Journal:  Cancer Res       Date:  2013-06-21       Impact factor: 12.701

5.  Gene Signatures of 1,25-Dihydroxyvitamin D3 Exposure in Normal and Transformed Mammary Cells.

Authors:  Katrina M Simmons; Sarah G Beaudin; Carmen J Narvaez; JoEllen Welsh
Journal:  J Cell Biochem       Date:  2015-08       Impact factor: 4.429

6.  Quantitative kinetic study of the actin-bundling protein L-plastin and of its impact on actin turn-over.

Authors:  Ziad Al Tanoury; Elisabeth Schaffner-Reckinger; Aliaksandr Halavatyi; Céline Hoffmann; Michèle Moes; Ermin Hadzic; Marie Catillon; Mikalai Yatskou; Evelyne Friederich
Journal:  PLoS One       Date:  2010-02-15       Impact factor: 3.240

7.  Novel breast cancer metastasis-associated proteins.

Authors:  Jiapei Ho; Jacklyn-Wai-Fun Kong; Lee-Yee Choong; Marie-Chiew-Shia Loh; Weiyi Toy; Poh-Kuan Chong; Chee-Hong Wong; Chow-Yin Wong; Nilesh Shah; Yoon-Pin Lim
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

8.  starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data.

Authors:  Jian-Hua Yang; Jun-Hao Li; Peng Shao; Hui Zhou; Yue-Qin Chen; Liang-Hu Qu
Journal:  Nucleic Acids Res       Date:  2010-10-30       Impact factor: 16.971

9.  ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancers.

Authors:  Paola D Vermeer; Megan Bell; Kimberly Lee; Daniel W Vermeer; Byrant G Wieking; Erhan Bilal; Gyan Bhanot; Ronny I Drapkin; Shridar Ganesan; Aloysius J Klingelhutz; Wiljan J Hendriks; John H Lee
Journal:  PLoS One       Date:  2012-01-18       Impact factor: 3.240

10.  Decreased expression of key tumour suppressor microRNAs is associated with lymph node metastases in triple negative breast cancer.

Authors:  Kelly A Avery-Kiejda; Stephen G Braye; Andrea Mathe; John F Forbes; Rodney J Scott
Journal:  BMC Cancer       Date:  2014-01-31       Impact factor: 4.430

View more
  23 in total

Review 1.  Advances in decoding breast cancer brain metastasis.

Authors:  Chenyu Zhang; Dihua Yu
Journal:  Cancer Metastasis Rev       Date:  2016-12       Impact factor: 9.264

2.  Analysis of the small non-protein-coding RNA profile of mouse spermatozoa reveals specific enrichment of piRNAs within mature spermatozoa.

Authors:  Kate Hutcheon; Eileen A McLaughlin; Simone J Stanger; Ilana R Bernstein; Matthew D Dun; Andrew L Eamens; Brett Nixon
Journal:  RNA Biol       Date:  2017-09-21       Impact factor: 4.652

3.  Targeted core-shell nanoparticles for precise CTCF gene insert in treatment of metastatic breast cancer.

Authors:  Jialun Duan; Chunjie Bao; Ying Xie; Haitao Guo; Yixuan Liu; Jianwei Li; Rui Liu; Peishan Li; Jing Bai; Yan Yan; Limin Mu; Xueqi Li; Guiling Wang; Wanliang Lu
Journal:  Bioact Mater       Date:  2021-10-07

4.  IL13Rα2 Promotes Proliferation and Outgrowth of Breast Cancer Brain Metastases.

Authors:  R Alejandro Márquez-Ortiz; Maria J Contreras-Zárate; Vesna Tesic; Karen L F Alvarez-Eraso; Gina Kwak; Zachary Littrell; James C Costello; Varsha Sreekanth; D Ryan Ormond; Sana D Karam; Peter Kabos; Diana M Cittelly
Journal:  Clin Cancer Res       Date:  2021-09-20       Impact factor: 12.531

5.  Metastasis-inducing proteins are widely expressed in human brain metastases and associated with intracranial progression and radiation response.

Authors:  Rasheed Zakaria; Angela Platt-Higgins; Nitika Rathi; Daniel Crooks; Andrew Brodbelt; Emmanuel Chavredakis; David Lawson; Michael D Jenkinson; Philip S Rudland
Journal:  Br J Cancer       Date:  2016-04-21       Impact factor: 7.640

6.  Modification of Crocodile Spermatozoa Refutes the Tenet That Post-testicular Sperm Maturation Is Restricted To Mammals.

Authors:  Brett Nixon; Stephen D Johnston; David A Skerrett-Byrne; Amanda L Anderson; Simone J Stanger; Elizabeth G Bromfield; Jacinta H Martin; Philip M Hansbro; Matthew D Dun
Journal:  Mol Cell Proteomics       Date:  2018-08-02       Impact factor: 5.911

7.  Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography.

Authors:  C Ryan Oliver; Trisha M Westerhof; Maria G Castro; Sofia D Merajver
Journal:  J Vis Exp       Date:  2020-08-16       Impact factor: 1.355

8.  Acquisition of Invasiveness by Breast Adenocarcinoma Cells Engages Established Hallmarks and Novel Regulatory Mechanisms.

Authors:  Hanaa Mousa; Mahmoud Elgamal; Reham Ghazal Marei; Nazariy Souchelnytskyi; Kah-Wai Lin; Serhiy Souchelnytskyi
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

9.  Effects of FSTL1 on cell proliferation in breast cancer cell line MDA‑MB‑231 and its brain metastatic variant MDA‑MB‑231‑BR.

Authors:  Jiaqiang An; Lulu Wang; Yuanli Zhao; Qiang Hao; Ying Zhang; Jingyi Zhang; Chun Yang; Li Liu; Wenjuan Wang; Dongliang Fang; Tao Lu; Yan Gao
Journal:  Oncol Rep       Date:  2017-09-26       Impact factor: 3.906

10.  Tumor Cell Mechanosensing During Incorporation into the Brain Microvascular Endothelium.

Authors:  Marina A Pranda; Kelsey M Gray; Ariana Joy L DeCastro; Gregory M Dawson; Jae W Jung; Kimberly M Stroka
Journal:  Cell Mol Bioeng       Date:  2019-08-28       Impact factor: 2.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.